http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201617984-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e1704eae429f9cbcac4fed732bd8921
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b916b7b625bea15e747b6227c244a68d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c46442fbb184b4b12ee26b36d6b9e43e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6637b24d9c78168dc31848682211b7db
publicationDate 2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-201617984-A2
titleOfInvention PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN
abstract The present invention relates to a pharmaceutical composition in the form of dabigatran etexylate free base or pharmaceutically acceptable salts of dabigatran etexylate and at least one pharmaceutically acceptable excipient.
priorityDate 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210

Total number of triples: 18.